Fundacion Centro de Investigaciones Clinicas CARDIOMET
About Fundacion Centro de Investigaciones Clinicas CARDIOMET
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Allergan
3
Inovio Pharmaceuticals
1
Clinical Trials at Fundacion Centro de Investigaciones Clinicas CARDIOMET
During the past decade, Fundacion Centro de Investigaciones Clinicas CARDIOMET conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
2018-02-01
2020-11-05
Terminated
450
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
2018-01-24
2020-10-30
Terminated
467
Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02
2018-02-16
2020-07-16
Terminated
311
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure
2020-11-30
2022-09-13
Terminated
1,308
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion Centro de Investigaciones Clinicas CARDIOMET"
#1 collaborator was "Advaccine (Suzhou) Biopharmaceuticals Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Fundacion Centro de Investigaciones Clinicas CARDIOMET
According to Clinical.Site data, the most researched conditions in "Fundacion Centro de Investigaciones Clinicas CARDIOMET" are
"Diabetes Mellitus" (3 trials), "Gastroparesis" (3 trials), "COVID-19 Disease" (1 trials), "Coronavirus Infection" (1 trials) and "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)" (1 trials). Many other conditions were trialed in "Fundacion Centro de Investigaciones Clinicas CARDIOMET" in a lesser frequency.
Clinical Trials Intervention Types at Fundacion Centro de Investigaciones Clinicas CARDIOMET
Most popular intervention types in "Fundacion Centro de Investigaciones Clinicas CARDIOMET" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Relamorelin" (3 trials), "CELLECTRA® 2000" (1 trials) and "INO-4800" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fundacion Centro de Investigaciones Clinicas CARDIOMET
The vast majority of trials in "Fundacion Centro de Investigaciones Clinicas CARDIOMET" are
4 trials for "All" genders.
Clinical Trials Status at Fundacion Centro de Investigaciones Clinicas CARDIOMET
Currently, there are NaN active trials in "Fundacion Centro de Investigaciones Clinicas CARDIOMET".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Fundacion Centro de Investigaciones Clinicas CARDIOMET,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Fundacion Centro de Investigaciones Clinicas CARDIOMET, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".